https://www.selleckchem.com/pr....oducts/reparixin-rep
Results Preintervention, the percentage of individuals with depression who received CP was higher among males (CP 58.4%, MACP 13.6%) than females (CP 57.1%, MACP 10.9%). In contrast, the percentage who received AT was higher among females (AT 57.7%, MAAT 47.4%) than males (AT 53.6%, MAAT 41.9%). These statistically significant sex/gender differences remain unchanged postintervention. Conclusions Sex/gender differences in depression care persist despite the introduction of physician incentives. © Joseph H. Puyat and Arminee
Like
Comment
Share
